293 related articles for article (PubMed ID: 33497524)
1. Gene correction of the CLN3 c.175G>A variant in patient-derived induced pluripotent stem cells prevents pathological changes in retinal organoids.
Zhang X; Zhang D; Thompson JA; Chen SC; Huang Z; Jennings L; McLaren TL; Lamey TM; De Roach JN; Chen FK; McLenachan S
Mol Genet Genomic Med; 2021 Mar; 9(3):e1601. PubMed ID: 33497524
[TBL] [Abstract][Full Text] [Related]
2. Clinical and molecular characterization of non-syndromic retinal dystrophy due to c.175G>A mutation in ceroid lipofuscinosis neuronal 3 (CLN3).
Chen FK; Zhang X; Eintracht J; Zhang D; Arunachalam S; Thompson JA; Chelva E; Mallon D; Chen SC; McLaren T; Lamey T; De Roach J; McLenachan S
Doc Ophthalmol; 2019 Feb; 138(1):55-70. PubMed ID: 30446867
[TBL] [Abstract][Full Text] [Related]
3. Characterization of CRB1 splicing in retinal organoids derived from a patient with adult-onset rod-cone dystrophy caused by the c.1892A>G and c.2548G>A variants.
Zhang X; Thompson JA; Zhang D; Charng J; Arunachalam S; McLaren TL; Lamey TM; De Roach JN; Jennings L; McLenachan S; Chen FK
Mol Genet Genomic Med; 2020 Nov; 8(11):e1489. PubMed ID: 32931148
[TBL] [Abstract][Full Text] [Related]
4. A human model of Batten disease shows role of CLN3 in phagocytosis at the photoreceptor-RPE interface.
Tang C; Han J; Dalvi S; Manian K; Winschel L; Volland S; Soto CA; Galloway CA; Spencer W; Roll M; Milliner C; Bonilha VL; Johnson TB; Latchney L; Weimer JM; Augustine EF; Mink JW; Gullapalli VK; Chung M; Williams DS; Singh R
Commun Biol; 2021 Feb; 4(1):161. PubMed ID: 33547385
[TBL] [Abstract][Full Text] [Related]
5. Synapse alterations precede neuronal damage and storage pathology in a human cerebral organoid model of CLN3-juvenile neuronal ceroid lipofuscinosis.
Gomez-Giro G; Arias-Fuenzalida J; Jarazo J; Zeuschner D; Ali M; Possemis N; Bolognin S; Halder R; Jäger C; Kuper WFE; van Hasselt PM; Zaehres H; Del Sol A; van der Putten H; Schöler HR; Schwamborn JC
Acta Neuropathol Commun; 2019 Dec; 7(1):222. PubMed ID: 31888773
[TBL] [Abstract][Full Text] [Related]
6. Using Patient-Specific Induced Pluripotent Stem Cells and Wild-Type Mice to Develop a Gene Augmentation-Based Strategy to Treat CLN3-Associated Retinal Degeneration.
Wiley LA; Burnight ER; Drack AV; Banach BB; Ochoa D; Cranston CM; Madumba RA; East JS; Mullins RF; Stone EM; Tucker BA
Hum Gene Ther; 2016 Oct; 27(10):835-846. PubMed ID: 27400765
[TBL] [Abstract][Full Text] [Related]
7. Novel homozygous CLN3 missense variant in isolated retinal dystrophy: A case report and electron microscopic findings.
Mizobuchi K; Hayashi T; Yoshitake K; Fujinami K; Tachibana T; Tsunoda K; Iwata T; Nakano T
Mol Genet Genomic Med; 2020 Aug; 8(8):e1308. PubMed ID: 32441891
[TBL] [Abstract][Full Text] [Related]
8. Unbiased Cell-based Screening in a Neuronal Cell Model of Batten Disease Highlights an Interaction between Ca2+ Homeostasis, Autophagy, and CLN3 Protein Function.
Chandrachud U; Walker MW; Simas AM; Heetveld S; Petcherski A; Klein M; Oh H; Wolf P; Zhao WN; Norton S; Haggarty SJ; Lloyd-Evans E; Cotman SL
J Biol Chem; 2015 Jun; 290(23):14361-80. PubMed ID: 25878248
[TBL] [Abstract][Full Text] [Related]
9. Retinal pathology and function in a Cln3 knockout mouse model of juvenile Neuronal Ceroid Lipofuscinosis (batten disease).
Seigel GM; Lotery A; Kummer A; Bernard DJ; Greene ND; Turmaine M; Derksen T; Nussbaum RL; Davidson B; Wagner J; Mitchison HM
Mol Cell Neurosci; 2002 Apr; 19(4):515-27. PubMed ID: 11988019
[TBL] [Abstract][Full Text] [Related]
10. Retinal Phenotype of Patients With Isolated Retinal Degeneration Due to CLN3 Pathogenic Variants in a French Retinitis Pigmentosa Cohort.
Smirnov VM; Nassisi M; Solis Hernandez C; Méjécase C; El Shamieh S; Condroyer C; Antonio A; Meunier I; Andrieu C; Defoort-Dhellemmes S; Mohand-Said S; Sahel JA; Audo I; Zeitz C
JAMA Ophthalmol; 2021 Mar; 139(3):278-291. PubMed ID: 33507216
[TBL] [Abstract][Full Text] [Related]
11. Transcript and in silico analysis of CLN3 in juvenile neuronal ceroid lipofuscinosis and associated mouse models.
Chan CH; Mitchison HM; Pearce DA
Hum Mol Genet; 2008 Nov; 17(21):3332-9. PubMed ID: 18678598
[TBL] [Abstract][Full Text] [Related]
12. Lysosomal alterations and decreased electrophysiological activity in CLN3 disease patient-derived cortical neurons.
Chear S; Perry S; Wilson R; Bindoff A; Talbot J; Ware TL; Grubman A; Vickers JC; Pébay A; Ruddle JB; King AE; Hewitt AW; Cook AL
Dis Model Mech; 2022 Dec; 15(12):. PubMed ID: 36453132
[TBL] [Abstract][Full Text] [Related]
13. Histopathologic and immunocytochemical analysis of the retina and ocular tissues in Batten disease.
Bensaoula T; Shibuya H; Katz ML; Smith JE; Johnson GS; John SK; Milam AH
Ophthalmology; 2000 Sep; 107(9):1746-53. PubMed ID: 10964839
[TBL] [Abstract][Full Text] [Related]
14. Immunomodulation with minocycline rescues retinal degeneration in juvenile neuronal ceroid lipofuscinosis mice highly susceptible to light damage.
Dannhausen K; Möhle C; Langmann T
Dis Model Mech; 2018 Sep; 11(9):. PubMed ID: 30042155
[TBL] [Abstract][Full Text] [Related]
15. Generation of an induced pluripotent stem cell line from a patient with non-syndromic CLN3-associated retinal degeneration and a coisogenic control line.
Zhang X; Zhang D; Chen SC; Lamey T; Thompson JA; McLaren T; De Roach JN; Chen FK; McLenachan S
Stem Cell Res; 2018 May; 29():245-249. PubMed ID: 29753273
[TBL] [Abstract][Full Text] [Related]
16. Profound infantile neuroretinal dysfunction in a heterozygote for the CLN3 genetic defect.
de los Reyes E; Dyken PR; Phillips P; Brodsky M; Bates S; Glasier C; Mrak RE
J Child Neurol; 2004 Jan; 19(1):42-6. PubMed ID: 15032383
[TBL] [Abstract][Full Text] [Related]
17. CLN3 deficiency leads to neurological and metabolic perturbations during early development.
Heins-Marroquin U; Singh RR; Perathoner S; Gavotto F; Merino Ruiz C; Patraskaki M; Gomez-Giro G; Kleine Borgmann F; Meyer M; Carpentier A; Warmoes MO; Jäger C; Mittelbronn M; Schwamborn JC; Cordero-Maldonado ML; Crawford AD; Schymanski EL; Linster CL
Life Sci Alliance; 2024 Mar; 7(3):. PubMed ID: 38195117
[TBL] [Abstract][Full Text] [Related]
18. Gene Therapy Targeting the Inner Retina Rescues the Retinal Phenotype in a Mouse Model of CLN3 Batten Disease.
Kleine Holthaus SM; Aristorena M; Maswood R; Semenyuk O; Hoke J; Hare A; Smith AJ; Mole SE; Ali RR
Hum Gene Ther; 2020 Jul; 31(13-14):709-718. PubMed ID: 32578444
[TBL] [Abstract][Full Text] [Related]
19. A recessive
Reith RR; Batt MC; Fuller AM; Meekins JM; Diehl KA; Zhou Y; Bedwell PS; Ward JA; Sanders SK; Petersen JL; Steffen DJ
J Vet Diagn Invest; 2024 May; 36(3):438-446. PubMed ID: 38516801
[TBL] [Abstract][Full Text] [Related]
20. Cln3-mutations underlying juvenile neuronal ceroid lipofuscinosis cause significantly reduced levels of Palmitoyl-protein thioesterases-1 (Ppt1)-protein and Ppt1-enzyme activity in the lysosome.
Appu AP; Bagh MB; Sadhukhan T; Mondal A; Casey S; Mukherjee AB
J Inherit Metab Dis; 2019 Sep; 42(5):944-954. PubMed ID: 31025705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
